First author | Population, year | MRSA incidence per 100,000 | MSSA incidence per 100,000 | Total incidence per 100,000 | Comments |
El Atrouni[1] | United States (adults), 1998 to 2005 | 12.4 | 25.4 | 38.2 | Overall SAB incidence stable during the study period, but the proportion due to MRSA increased. |
Klevens[2] | United States, 2005 | 23.9 | N/A | N/A | Most invasive MRSA infections were health care associated. |
Kallen[3] | United States (health care-associated infections only), 2005 to 2008 | 25.7 | N/A | N/A | Hospital-onset and health care-associated MRSA bacteremia decreased 34 and 20 percent, respectively, over the four-year period. |
Rhee[4] | United States, 2007 to 2013 | 16.1 | 29.6 | 45.7 | Community-onset MRSA bacteremia incidence stable during the study period and largely due to USA300 strain type. |
Allard[5] | Canada (adults), 1991 to 2005 | 3.3 | 24.3 | 27.6 | MRSA incidence increased from 0 to 7.4 per 100,000, while MSSA incidence remained stable. |
Mejer[6] | Denmark (adults), 1995 to 2008 | 0.18 | 22.5 | 22.7 | Overall SAB incidence stable, and 30-day mortality rate improved during the study period. |
Asgeirsson[7] | Iceland (adults), 1995 to 2008 | 0.15 | 24.4 | 24.5 | SAB incidence increased during the study period, but mortality improved. |
Huggan[8] | New Zealand, 1998 to 2005 | 0.08 | 21.4 | 21.5 | Rates stable over time. |
Laupland[9] | Multinational (Australia, Canada, Denmark, Finland, Sweden), 2000 to 2008 | 1.9 | 24.2 | 26.1 | Community-onset MSSA incidence was similar among study regions. Rates of MRSA and hospital MSSA varied considerably by region. No overall change in burden of SAB over time. |
Jacobsson[10] | Sweden, 2003 to 2005 | 0 | 27.6 | 27.6 | All cases were MSSA. |
Skogberg[11] | Finland, 2004 to 2007 | N/A | N/A | 20 | SAB associated with higher case-fatality rate than other pathogens. |
Tong[12] | Australia, 2006 to 2007 | 16 | 49 | 65 | SAB incidence rate in the indigenous Australian population was 172 per 100,000. |
Tong[13] | Australia, 2007 to 2010 | N/A | N/A | 11.2 | SAB rates higher in indigenous Australians, especially for community-associated MRSA. |
Taylor[14] | Canada, 2011 to 2013 | 3.95 | N/A | N/A | 66.9 percent of cases were community acquired and 33.1 percent hospital acquired. |
van Cleef[15] | Netherlands, 2009 | 0.18 | 19.1 | 19.3 | Cross-border comparison between Netherlands and North Rhine-Westphalia, Germany, showing 32-fold higher MRSA bacteremia incidence in Germany. |
Germany, 2009 | 5.76 | N/A | N/A | ||
Rates in specific subpopulations | |||||
Landrum[16] | United States (military), 2005 to 2010 | 2.0 | 2.7 | 4.7 | Rates of both MRSA and MSSA bacteremia decreased during the study period. |
Larsen[17] | Denmark (HIV-infected adults), 1995 to 2007 | 4.9 | 489 | 494 | 50 percent of initial episodes of SAB were in IDUs. |
Burkey[18] | United States (HIV-infected adults), 2000 to 2004 | 850 | 1110 | 1960 | 74.7 percent of MRSA bacteremia episodes in IDUs. |
Fitzgerald[19] | Ireland (hemodialysis recipients), 1998 to 2009 | 5600 | 11400 | 17000 | Intravascular catheters implicated as the source in 83 percent of cases. |
Wang[20] | Taiwan (all dialysis recipients), 2003 to 2008 | 1131 | 678 | 1809 | SAB more common among hemodialysis recipients than peritoneal dialysis. |
Jaganath[21] | Rural Thailand, 2006 to 2014 | 0.55 | 6.8 | 7.3 | Community-onset SAB incidence increased during the study period |
Jokinen[22] | Filand, 2005 to 2015 | 0.6 to 4.5 | 19.9 to 35.2 | 21.6 to 37.2 | MSSA and PSSA bacteremia incidence increased, whereas MRSA incidence peaked in 2011 |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟